Madden Securities Corp Biomarin Pharmaceutical Inc Transaction History

Madden Securities Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$74.73 - $90.69 $1.56 Million - $1.89 Million	-20,850 Closed	0 $0
Q4 2020 Jan 12, 2021	BUY	$72.61 - $90.2 $287,898 - $357,643	3,965 Added 23.48%	20,850 $1.83 Million
Q3 2020 Oct 08, 2020	BUY	$71.87 - $131.03 $1.21 Million - $2.21 Million	16,885 New	16,885 $1.29 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

Stay updated on Madden Securities Corp with notifications on news.